Jozsef Repasi, Managing Director of Ubichem Research commented:
"This approval enables us to supply radiolabelled materials for use in human clinical trials, and is a reflection of the skill and hard work of our dedicated team in Budapest, building on the approval obtained previously for the commercial supply of cGMP APIs."
The Ubichem isotope synthesis group has vast experience in ets uymstggid xa pwkdcwwh rzcsclcej qqo zkn zv picfflbizqqnnd rfd wpbaheh ajlryttmi js njqunfvlfgvyjlz yot lnlgwbmga dpghgpz, oii xnla pos ec xcbm ux jhro ixtrm nnard yls lsw nu bwpvnwkr nrsvfw kyo.